ABBV:BCBA
Abbvie Inc Cedear
ARS 42,420.00
arrow_downward
-0.33%(-140.00) 1D
Sep 30, 5:00:00 PM GMT-3 · ARS
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
ARS 42,800.00
High
ARS 42,800.00
Low
ARS 42,260.00
Mkt. cap
462.26B
Avg. vol.
0.00
Volume
1.03K
52-wk high
ARS 43,600.00
52-wk low
ARS 28,420.00
Shares outstanding
1.77B
No. of employees
57K
Open
ARS 42,800.00
High
ARS 42,800.00
Low
ARS 42,260.00
Mkt. cap
462.26B
Avg. vol.
0.00
Volume
1.03K
52-wk high
ARS 43,600.00
52-wk low
ARS 28,420.00
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Pluang
·
24 minutes ago
AbbVie to release Q3 2026 earnings on Oct 30 be...
TradingView
·
40 minutes ago
AbbVie to Host Third-Quarter 2026 Earnings Conference Call
AD HOC NEWS
·
6 hours ago
AbbVie stock pre-market at EUR 231.40: minus 0.09 percent
The Motley Fool
·
19 hours ago
AbbVie Stock: Buy, Sell, or Hold in October?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Inc Cedear
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com